Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China

KPC-producing Klebsiella pneumoniae (KPC-KP) is the most widely spread carbapenem-resistant Enterobacteriaceae (CRE) in China. Avibactam is a novel non-β-lactam β-lactamase inhibitor which is highly active against KPC. Recently, ceftazidime-avibactam (CAZ-AVI) was approved for clinical treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Xiaoyan, Shan, Bin, Zhang, Xue, Qu, Fen, Jia, Wei, Huang, Bin, Yu, Hua, Tang, Yi-Wei, Chen, Liang, Du, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324628/
https://www.ncbi.nlm.nih.gov/pubmed/32655534
http://dx.doi.org/10.3389/fmicb.2020.01365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324628/
https://www.ncbi.nlm.nih.gov/pubmed/32655534
http://dx.doi.org/10.3389/fmicb.2020.01365

Ejemplares similares